Abbott Labs Stock Offers Favorable Entry Point Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.8592 of 5 stars$127.28-1.7%1.85%16.64 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | Sponsored7 of the Best Options for Investing $5,000 in 2025Part of managing your money is taking calculated risks to help your money work for you. That means, whether yo...MarketBeatMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored15 Healthcare Stocks that Analysts Love in a Post-Pandemic WorldThere are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...MarketBeatVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored7 Industrial Stocks with Safe, Growing DividendsHistory shows that industrial stocks tend to underperform the market in a rising interest rate environment. Th...MarketBeat Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersSizing Up a New Opportunity for NVIDIA InvestorsJanuary 27, 2025View Sizing Up a New Opportunity for NVIDIA InvestorsGrab This Altcoin Before Trump's Crypto AnnouncementFrom Crypto 101 Media(Ad)View Grab This Altcoin Before Trump's Crypto Announcement3 Buy-and-Hold Stocks for Long-Term GrowthJanuary 24, 2025View 3 Buy-and-Hold Stocks for Long-Term GrowthPelosi Bets Big on AI: This Is What You Need to KnowJanuary 22, 2025View Pelosi Bets Big on AI: This Is What You Need to KnowMarket Momentum: 3 Stocks Poised for Significant BreakoutsJanuary 23, 2025View Market Momentum: 3 Stocks Poised for Significant BreakoutsThis Crypto Is Set to Explode in JanuaryFrom Crypto 101 Media(Ad)View This Crypto Is Set to Explode in January Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.8592 of 5 stars$127.28-1.7%1.85%16.64 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | Sponsored7 of the Best Options for Investing $5,000 in 2025Part of managing your money is taking calculated risks to help your money work for you. That means, whether yo...MarketBeatMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored15 Healthcare Stocks that Analysts Love in a Post-Pandemic WorldThere are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...MarketBeatVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored7 Industrial Stocks with Safe, Growing DividendsHistory shows that industrial stocks tend to underperform the market in a rising interest rate environment. Th...MarketBeat
